CCA
MRNA icon

Column Capital Advisors’s Moderna MRNA Stock Holding History

Column Capital Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$117K Hold
117,112
– – 0.02% 201
2023
Q2 		$117K Hold
117,112
– – 0.02% 197
2023
Q1 		$117K Sell
117,112
-9
-0% -$1.49K 0.02% 200
2022
Q4 		$119K Buy
+117,121
New +$19.2M 0.02% 183
2022
Q1 		– Sell
-1
Closed – – 780
2021
Q4 		$0 Buy
+1
New +$292 ﹤0.01% 813
2020
Q1 		– Sell
-162
Closed -$3K – 765
2019
Q4 		$3K Buy
+162
New +$2.87K ﹤0.01% 582

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Column Capital Advisors's MRNA Position: Q3 2023 in Review

Column Capital Advisors held its Moderna (MRNA) position steady in Q3 2023 at 117,112 shares worth $117K. The position accounts for 0.02% of the portfolio, ranked #201.

Column Capital Advisors first reported a position in MRNA in Q4 2019 and has held it in 6 quarters since. The position peaked at $119K in Q4 2022. 888 funds tracked by Wall St. Rank hold MRNA as of Q3 2023.

  • Column Capital Advisors held 117,112 shares of Moderna worth $117K as of Q3 2023.
  • Column Capital Advisors left its Moderna share count unchanged in Q3 2023.
  • Moderna made up 0.02% of Column Capital Advisors's portfolio in Q3 2023, its #201 holding.
  • Column Capital Advisors first reported a position in Moderna in Q4 2019 and has held it in 6 quarters since.
  • Column Capital Advisors's Moderna position peaked at $119K in Q4 2022.
  • 888 funds tracked by Wall St. Rank held Moderna as of Q3 2023.

Based on Column Capital Advisors's 13F filing for Q3 2023, filed 3 Nov 2023.